TickerFactsScreenerDevelopers

Akebia Therapeutics, Inc. (AKBA) — Operating Cash Flow

Annual figures by fiscal year, from SEC filings.

2016: $57.91M2017: -$56.16M2018: -$97.49M2019: -$257.44M2020: -$110.39M2021: -$252.97M2022: -$73.15M2023: -$23.38M2024: -$40.66M2025: $67.99M$67.99M
2016Operating Cash Flow (USD)2025
Fiscal YearOperating Cash FlowChange YoY
2025$67.99M+267.2%
2024-$40.66M-73.9%
2023-$23.38M+68.0%
2022-$73.15M+71.1%
2021-$252.97M-129.2%
2020-$110.39M+57.1%
2019-$257.44M-164.1%
2018-$97.49M-73.6%
2017-$56.16M-197.0%
2016$57.91M—